Spots Global Cancer Trial Database for Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Official Title: Long-Term Follow-Up (LTFU) of Participants Treated With GSK Adoptive Cell Therapies
Study ID: NCT03391778
Conditions
Interventions
Study Description
Brief Summary: This trial will evaluate long term safety of participants who have received GlaxoSmithKline (GSK) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Detailed Description: Participants who received a GSK adoptive cell therapy will be enrolled in this non-therapeutic, multi-center, long term follow-up (LTFU) study and will be followed for up to 15 years post-infusion of lentiviral vector-based adoptive cell therapy. Participants will be monitored for safety following last adoptive cell therapy infusion.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Bethesda, Maryland, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Ann Arbor, Michigan, United States
GSK Investigational Site, Saint Louis, Missouri, United States
GSK Investigational Site, New York, New York, United States
GSK Investigational Site, Durham, North Carolina, United States
GSK Investigational Site, Portland, Oregon, United States
GSK Investigational Site, Philadelphia, Pennsylvania, United States
GSK Investigational Site, Pittsburgh, Pennsylvania, United States
GSK Investigational Site, Dallas, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Milwaukee, Wisconsin, United States
GSK Investigational Site, Melbourne, Victoria, Australia
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Barcelona, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Sevilla, , Spain
GSK Investigational Site, London, , United Kingdom
GSK Investigational Site, Manchester, , United Kingdom
GSK Investigational Site, Sutton, , United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
